Drug intelligence / Profile preview

2-(4-chlorobenzylamino)-4-(phenylamino)pyrazolo[1,5-a][1,3,5]triazine-8-carbonitrile

Development stage
Unknown
01

Overview

**Description:** This compound is a synthetic chemical entity featuring the core structure of pyrazolotriazine substituted at multiple positions. It is not currently marketed as a drug and does not have an established clinical indication or mechanism of action in the literature. The compound appears in chemical databases such as PubChem and Pharos but lacks detailed pharmacological or clinical data. Its molecular formula is C19H14ClN7 and its molecular weight is approximately 375.8 g/mol.

Other names
2-(4-chlorobenzylamino)-4-(phenylamino)pyrazolo[1,5-a][1,3,5]triazine-8-carbonitrile2-{[(4-chlorophenyl)methyl]amino}-4-(phenylamino)pyrazolo[1,5-a][1,3,5]triazine-8-carbonitrile2-(((4-chlorophenyl)methyl)amino)-4-(phenylamino)pyrazolo(1,5-a)(1,3,5)triazine-8-carbonitrile2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO(1,5-A)(1,3,5)TRIAZINE-8-CARBONITRILE
02

Targets

CK2 (Casein kinase II subunit alpha)

Beyond the preview

Go deeper on 2-(4-chlorobenzylamino)-4-(phenylamino)pyrazolo[1,5-a][1,3,5]triazine-8-carbonitrile.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2-(4-chlorobenzylamino)-4-(phenylamino)pyrazolo[1,5-a][1,3,5]triazine-8-carbonitrile.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call